Transcriptional determinants of cancer immunotherapy response and resistance is a research paper published in Trends in cancer (2022). On theSindex it has a DataRank of 0.449. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA200919-01
National Institutes of Health
Grant: R01CA195077-01A1
National Institutes of Health
Grant: R01 CA218008-01A1
National Institutes of Health
Grant: R01CA233481
National Institutes of Health
Grant: R03CA248913
National Institutes of Health
Grant: R03 CA230815
NCI NIH HHS
Grant: R01 CA200919
NCI NIH HHS
Grant: R01 CA257046
NCI NIH HHS
Grant: R01 CA218008
NCI NIH HHS
Grant: R21 CA195077
Novartis
Kyowa Kirin Pharmaceutical Development
AstraZeneca
Gilead Sciences
TG Therapeutics
FWCI
1.68
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals